Genomic therapy matching in rare and refractory cancers: Updated results from a retrospective cohort study in the Molecular Screening and Therapeutic (MoST) program.

Frank Lin, David M. Thomas, Christine E. Napier et al.|Journal of Clinical Oncology|2023

Cited by 2